Concepedia

Kara Scheibner

KS

14

Publications

1.3K

Citations

13

H-Index

2001

Active since

Affiliations

Johns Hopkins Medicine(Current)

University of Maryland, Baltimore

Health Canada

GlaxoSmithKline (United States)

Pfizer (United States)

Kara Scheibner is an author at Johns Hopkins Medicine specializing in medicine, biochemistry, and immunology.

Top concepts

Publications per year

2001–2024

14

Publications

14

Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2

Kara Scheibner, Michael A. Lutz, Sada Boodoo et al. · The Journal of Immunology · 2006 · 684 citations · Full text

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner et al. · Blood · 2013 · 143 citations · Full text

2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)

Shalini Gupta, Susan Richards, Lakshmi Amaravadi et al. · Bioanalysis · 2017 · 65 citations · Full text

, , +27

c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias

Nidal Muvarak, Shannon Kelley, Carine Robert et al. · Molecular Cancer Research · 2015 · 63 citations · Full text

MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ

Kara Scheibner, Brianne Teaboldt, Mary Claire Hauer et al. · PLoS ONE · 2012 · 62 citations · Full text

, , +18

Rows per page

1–5 of 14